GUANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Sunshine Lake Pharma Co., Ltd. (06887.HK) announced that the company will officially list on the Hong Kong Stock...
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells
Robotics company WorkFar invites companies interested in reshoring their manufacturing operations to set up shop in its massive, US-based manufacturing footprint that boasts Industry...
Series 3 Secure Vault, debuting on the SiXG301 SoC in the next-gen Series 3 lineup, achieves highest security certification for advanced IoT protection
AUSTIN, Texas,...
PHOENIX, Aug. 4, 2025 /PRNewswire/ -- Grid8, a leader in AI-powered interconnection solutions, today announced the launch of its new Interconnection Dashboard, a free tool...
Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.
Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs
Respective Generics Businesses and Endo's Sterile Injectables Business to be Combined and Spun...
HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (“NCS” or the “Company”) today announced that it has acquired ResMetrics LLC (“ResMetrics”), a leading provider of chemical tracer diagnostics services used by oil and gas operators to validate reservoir development strategies, improve hydraulic fracture stimulation designs, evaluate inter-well connectivity, and optimize enhanced oil recovery injection programs, complementing and further strengthening NCS’s tracer diagnostics capabilities.
Facephi, a leading provider and developer in the identity verification sector, reinforces digital identity protection with its new feature, Advanced Injection Defense, designed to stop deepfakes and manipulated images and videos
Facephi, a leading provider and developer in the identity verification sector, reinforces digital identity protection with its new feature, Advanced Injection Defense, designed to stop deepfakes and manipulated images and videos
Landmark 30th Anniversary EnerCom Denver – The Energy Investment Conference Announces Energy Transition and Emerging Technology Session Schedule
Qualified Investors and Analysts Can Register at...